Amide Technologies

Founded with a mission to revolutionize protein discovery and engineering, Amide Technologies leverages artificial intelligence and solid-phase flow chemistry to rapidly design and build proteins from the ground up. The company focuses on creating innovative protein therapeutics and engineered proteins, aiming to rethink traditional methods in protein discovery and application. Their market focus includes pharmaceutical companies and research institutions seeking advanced solutions for protein synthesis and therapeutic development.

Amide Technologies has garnered attention from notable investors and industry experts due to its cutting-edge approach. The company has achieved significant milestones in synthesizing peptides that are difficult to obtain through existing methods, thus accelerating the pace of scientific discovery. By bridging the gap between traditional solid-phase peptide synthesis and biological expression, Amide Technologies has made a substantial impact on the field of protein therapeutics, positioning itself as a leader in AI-driven protein engineering.